Hematologic Malignancies News | Healio

Tell us what you think about Healio

Hematology/Oncology

Loading...

Sign in for a personal experience.

Customized content served to meet your interests.

All Specialties
Hematology/Oncology

Healio › Hematology/Oncology › Hematologic Malignancies › News

In the Journals
Kaposi’s sarcoma, lymphoma highest during first year of ART
June 17, 2013
Rates of Kaposi’s sarcoma and lymphoma were highest within the first year of antiretroviral treatment, but after the first year, other non–AIDS-defining...More »

In the Journals Perspective
Bendamustine plus rituximab shows promise in relapsed, refractory DLBCL
June 11, 2013
The combination of bendamustine and rituximab was effective and well tolerated as salvage therapy in patients with relapsed or refractory diffuse large...More »

Meeting News Coverage Perspective
Obinutuzumab, rituximab improved chlorambucil efficacy in CLL
June 7, 2013
CHICAGO — Response rates and survival outcomes with chlorambucil plus obinutuzumab or rituximab were superior to those with chlorambucil alone in a...More »

Meeting News Coverage Video
Elderly patients with CLL benefit from combination therapies vs. chlorambucil alone
June 7, 2013
CHICAGO — John C. Byrd, MD, the D. Warren Brown Professor of Leukemia Research at Ohio State University, discusses exciting research...More »

FDA approvals Perspective
FDA approves lenalidomide for treatment of mantle cell lymphoma
June 5, 2013
The FDA today approved the immunomodulating agent lenalidomide for the treatment of mantle cell lymphoma.
The approval of lenalidomide (Revlimid, Celgene)...More »

Meeting News Coverage Video
Focus on kinase inhibitors, limited efficacy of surveillance among significant developments at lymphoma sessions
June 4, 2013
CHICAGO – Bruce D. Cheson, MD, of the Georgetown Lombardi Comprehensive Cancer Center offers his opinions about the highlights of the lymphoma...More »

Meeting News Coverage
Routine surveillance imaging provided no survival benefit in HL
June 4, 2013
CHICAGO — A cohort of patients with classical Hodgkin’s lymphoma who were treated with routine surveillance imaging after complete remission...More »

Perspective
Regimen may help avoid radiotherapy in primary mediastinal B-cell lymphoma
HemOnc Today, June 10, 2013
The addition of rituximab to dose-adjusted etoposide, doxorubicin, and cyclophosphamide plus vincristine and prednisone eliminated the need for...More »

Meeting News Coverage Perspective
Few DLBCL relapses detected solely by post-treatment surveillance scans
May 31, 2013
Most diffuse large B-cell lymphoma relapses are detected by self-reported symptoms, physical exams or laboratory abnormalities rather than CT scans,...More »

Meeting News Coverage Perspective
Few DLBCL relapses detected solely by post-treatment surveillance scans
HemOnc Today, June 10, 2013
Most diffuse large B-cell lymphoma relapses are detected by self-reported symptoms, physical exams or laboratory abnormalities rather than CT scans,...More »

1
2
3
4
5
6
7
8
9
10
Next

Featured
Most Popular

In the Journals
Kaposi’s sarcoma, lymphoma highest during first year of ART
June 17, 2013

CME Article
A 60-Year-Old Male with Hairy-Cell Leukemia and Existential Distress
Psychiatric Annals, April 2012, Volume 42 Issue 4

Meeting News Coverage Perspective
PD-L1 targeted antibody induced tumor shrinkage in several cancer types
May 31, 2013

Cover Stories
Targeted therapies continue to improve outcomes in HER-2–positive breast cancer
HemOnc Today, June 10, 2013

In the Journals Perspective
VPS45 mutation associated with new immunodeficiency syndrome in children
June 17, 2013

Advertisement

Resources from Industry

[X]